Cargando…
Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations
BACKGROUND: Artemisinin-based combinations currently recommended for treatment of uncomplicated Plasmodium falciparum malaria in many countries of sub-Saharan Africa are substrates of CYP enzymes. The cytochrome enzyme system is responsible for metabolism of about 80-90% of clinically used drugs. It...
Autores principales: | Marwa, Karol J, Schmidt, Theresa, Sjögren, Maria, Minzi, Omary MS, Kamugisha, Erasmus, Swedberg, Göte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228099/ https://www.ncbi.nlm.nih.gov/pubmed/25363545 http://dx.doi.org/10.1186/1475-2875-13-420 |
Ejemplares similares
-
The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review
por: Marwa, Karol J, et al.
Publicado: (2023) -
Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania
por: Marwa, Karol J., et al.
Publicado: (2021) -
Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
por: Marwa, Karol J., et al.
Publicado: (2022) -
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis
por: Marwa, Karol, et al.
Publicado: (2022) -
Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)